Press Releases January 4, 2012Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy September 26, 2011Elevation Pharmaceuticals Presents Positive Phase 2a Results in COPD Patients at the European Respiratory Society Annual Congress September 26, 2011Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives – Company Draws Down $17 Million from Tranched Series A Financing January 21, 2010Elevation Pharmaceuticals Raises $30 Million in Series A Financing – Funds for clinical development of aerosol therapies in COPD
